GlassScriptPrepare for your visit
Jamie Keen
Ophthalmic Plastic and Reconstructive Surgery · Hines, IL · NPI 1144753500
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,334.14
in general payments reported to CMS, 2019-2025 · $387 in 2025
The $387 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Who reported paying
General payments only, top 6 by amount.
- Alcon Vision LLC $469.32
- Glaukos Corporation $202.65
- Amgen INC. $184.68
- Horizon Therapeutics Plc $175.50
- Beaver-Visitec International, INC. $146.30
- Tarsus Pharmaceuticals, INC. $125.07
Drugs and devices associated with these payments
Tepezza Istent Infinite Idosetr Xdemvy Rhopressa Rocklatan Simbrinza Syfovre
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jamie Keen listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5704583/jamie-keen